Track ASND and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
ASND - Ascendis Pharma AS (ASND) has a earnings per share of $0.27, up 117.1% over the past year.
Latest EPS (Actual)
$0.27
Beat Rate
25.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| Apr 2026 | $0.43 | $0.27 | Miss | -37.21% |
| Feb 2026 | -$0.24 | -$0.55 | Miss | -129.17% |
| Nov 2025 | -$0.16 | -$1.00 | Miss | -525.00% |
| Aug 2025 | -$1.42 | -$0.93 | Beat | +34.51% |
| May 2025 | -$1.51 | -$1.58 | Meet | -4.64% |
| Feb 2025 | -$0.93 | -$0.64 | Beat | +31.18% |
| Nov 2024 | -$1.49 | -$1.72 | Miss | -15.44% |
| Sep 2024 | -$1.46 | -$2.11 | Miss | -44.52% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.